The promise and perils of the peptide craze | Hindustan Times
A few days ago, a 45-year-old woman came to me seeking treatment for obesity. She was not diabetic, but was about 20 kilos overweight and could be a suitable candidate for…
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 30 20:40 ETSource: Hindustan Times
From the source
Read at hindustantimes.comThe promise and perils of the peptide craze | Hindustan Times
A few days ago, a 45-year-old woman came to me seeking treatment for obesity. She was not diabetic, but was about 20 kilos overweight and could be a suitable candidate for medication. I began explaining tirzepatide (Mounjaro), including its benefits and potential side effects. She cut me short. “I don’t want Mounjaro. I’ve heard a lot about its side effects.”
